Anticoagulation therapy and proximal femoral fracture treatment: An update

Hip fractures in the elderly population have become a ‘disease’ with increasing incidence. Most of the geriatric patients are affected by a number of comorbidities. Coagulopathies continue to be a special point of interest for the orthopaedic trauma surgeon, with the management of this high-risk gro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ktistakis, Ioannis, Giannoudis, Vasileios, Giannoudis, Peter V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: British Editorial Society of Bone and Joint Surgery 2016
Materias:
Trauma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367555/
https://www.ncbi.nlm.nih.gov/pubmed/28461962
http://dx.doi.org/10.1302/2058-5241.1.160034
Descripción
Sumario:Hip fractures in the elderly population have become a ‘disease’ with increasing incidence. Most of the geriatric patients are affected by a number of comorbidities. Coagulopathies continue to be a special point of interest for the orthopaedic trauma surgeon, with the management of this high-risk group of patients a hot topic of debate among the orthopaedic community. While a universal consensus on how to manage thromboprophylaxis for this special cohort of patients has not been reached, multiple attempts to define a widely accepted protocol have been published. Cite this article: Ktistakis I, Giannoudis V, Giannoudis PV. Anticoagulation therapy and proximal femoral fracture treatment: an update. EFORT Open Rev 2016;1:310-315. DOI: 10.1302/2058-5241.1.160034.

Ejemplares similares